Loading streams...
| All Content |
| RSS |
| View all podcasts & RSS feeds | ||
Originally published on Mon April 23, 2012 5:09 am
Swiss food and drink giant Nestle announced a deal Monday to acquire Pfizer Inc.'s infant-nutrition business for $11.85 billion in a bid to boost sales in emerging markets. Before the announcement, Nestle already had the largest share of the global baby-formula market at just under 20 percent.